US Stock MarketDetailed Quotes

Arrowhead Pharmaceuticals (ARWR)

Watchlist
  • 70.160
  • +0.570+0.82%
Trading Jan 23 11:02 ET
9.78BMarket Cap-7016.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arrowhead Pharmaceuticals (ARWR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
Total revenue
23,258.15%829.45M
256.47M
27.77M
542.71M
-29.60%2.5M
-98.52%3.55M
0
0
0
-94.32%3.55M
Operating revenue
23,258.15%829.45M
--256.47M
--27.77M
--542.71M
-29.60%2.5M
-98.52%3.55M
--0
--0
--0
-94.32%3.55M
Cost of revenue
Gross profit
Operating expense
20.92%731.1M
30.93%212.37M
9.75%193.32M
27.99%161.51M
17.00%163.91M
35.65%604.63M
30.36%162.2M
48.61%176.14M
28.63%126.19M
33.83%140.1M
Selling and administrative expenses
25.92%121.92M
44.17%37.18M
31.24%30.44M
13.19%27.89M
13.83%26.4M
6.48%96.82M
6.70%25.79M
-0.73%23.2M
8.01%24.64M
12.69%23.19M
-General and administrative expense
25.92%121.92M
44.17%37.18M
31.24%30.44M
13.19%27.89M
13.83%26.4M
6.48%96.82M
6.70%25.79M
-0.73%23.2M
8.01%24.64M
12.69%23.19M
Research and development costs
20.02%607.16M
28.61%174.69M
6.52%162.37M
31.63%133.1M
17.61%137M
43.23%505.87M
36.02%135.83M
60.87%152.43M
35.04%101.12M
39.19%116.49M
Depreciation amortization depletion
4.48%2.03M
-14.89%503K
-1.56%505K
20.24%511K
23.54%509K
20.04%1.94M
45.93%591K
26.98%513K
4.94%425K
2.23%412K
-Depreciation and amortization
4.48%2.03M
-14.89%503K
-1.56%505K
20.24%511K
23.54%509K
20.04%1.94M
45.93%591K
26.98%513K
4.94%425K
2.23%412K
Operating profit
116.36%98.35M
127.19%44.11M
6.01%-165.55M
402.08%381.2M
-18.21%-161.41M
-193.21%-601.08M
-49.73%-162.2M
-71.51%-176.14M
-362.00%-126.19M
-224.07%-136.55M
Net non-operating interest income expense
-440.61%-52.07M
-69.07%-12.64M
-1,051.78%-13.36M
-1,109.66%-12.02M
-447.52%-14.04M
-218.20%-9.63M
-442.99%-7.48M
242.39%1.4M
-100.00%-994K
-1,435.93%-2.57M
Non-operating interest income
64.12%37.29M
26.26%9.05M
69.58%11.02M
53.84%9.62M
171.31%7.6M
48.51%22.72M
84.56%7.17M
55.75%6.5M
37.06%6.25M
4.47%2.8M
Non-operating interest expense
176.21%89.36M
48.11%21.69M
378.64%24.38M
198.72%21.64M
303.32%21.65M
76.54%32.35M
178.35%14.65M
-1.24%5.09M
43.25%7.24M
88.38%5.37M
Other net income (expense)
400.86%5.26M
249.33%4.66M
-123.16%-176K
131.75%438K
-19.00%341K
-213.65%-1.75M
-534.87%-3.12M
148.37%760K
2,262.50%189K
-16.96%421K
Other non- operating income (expenses)
400.86%5.26M
249.33%4.66M
-123.16%-176K
131.75%438K
-19.00%341K
-213.65%-1.75M
-534.87%-3.12M
148.37%760K
2,262.50%189K
-16.96%421K
Income before tax
108.41%51.53M
120.90%36.12M
-2.94%-179.09M
391.05%369.62M
-26.26%-175.12M
-196.60%-612.46M
-58.54%-172.8M
-68.28%-173.98M
-366.37%-127M
-231.84%-138.69M
Income tax
874.09%21.42M
3,563.00%20M
-437K
1.75M
103.11%103K
-199.39%-2.77M
-73.04%546K
0
0
-19,588.24%-3.31M
Net income
104.94%30.11M
109.30%16.12M
-2.69%-178.65M
389.67%367.86M
-29.43%-175.22M
-191.34%-609.69M
-56.14%-173.34M
-67.08%-173.98M
-366.37%-127M
-223.78%-135.38M
Net income continuous Operations
104.94%30.11M
109.30%16.12M
-2.69%-178.65M
389.67%367.86M
-29.43%-175.22M
-191.34%-609.69M
-56.14%-173.34M
-67.08%-173.98M
-366.37%-127M
-223.78%-135.38M
Minority interest income
411.23%31.75M
1,519.91%39.87M
-7.13%-3.41M
-52.24%-2.58M
15.09%-2.13M
-155.00%-10.2M
-110.18%-2.81M
-170.06%-3.18M
-69.77%-1.7M
-416.87%-2.51M
Net income attributable to the parent company
99.73%-1.63M
86.07%-23.75M
-2.60%-175.24M
395.65%370.45M
-30.27%-173.09M
-192.04%-599.49M
-55.49%-170.54M
-65.91%-170.79M
-357.42%-125.3M
-221.51%-132.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
99.73%-1.63M
86.07%-23.75M
-2.60%-175.24M
395.65%370.45M
-30.27%-173.09M
-192.04%-599.49M
-55.49%-170.54M
-65.91%-170.79M
-357.42%-125.3M
-221.51%-132.86M
Basic earnings per share
99.80%-0.01
86.86%-0.18
8.70%-1.26
372.55%2.78
-12.10%-1.39
-160.42%-5
-34.31%-1.37
-43.75%-1.38
-321.74%-1.02
-217.95%-1.24
Diluted earnings per share
99.80%-0.01
86.86%-0.18
8.70%-1.26
369.61%2.75
-12.10%-1.39
-160.42%-5
-34.31%-1.37
-43.75%-1.38
-326.67%-1.02
-217.95%-1.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023
Total revenue 23,258.15%829.45M256.47M27.77M542.71M-29.60%2.5M-98.52%3.55M000-94.32%3.55M
Operating revenue 23,258.15%829.45M--256.47M--27.77M--542.71M-29.60%2.5M-98.52%3.55M--0--0--0-94.32%3.55M
Cost of revenue
Gross profit
Operating expense 20.92%731.1M30.93%212.37M9.75%193.32M27.99%161.51M17.00%163.91M35.65%604.63M30.36%162.2M48.61%176.14M28.63%126.19M33.83%140.1M
Selling and administrative expenses 25.92%121.92M44.17%37.18M31.24%30.44M13.19%27.89M13.83%26.4M6.48%96.82M6.70%25.79M-0.73%23.2M8.01%24.64M12.69%23.19M
-General and administrative expense 25.92%121.92M44.17%37.18M31.24%30.44M13.19%27.89M13.83%26.4M6.48%96.82M6.70%25.79M-0.73%23.2M8.01%24.64M12.69%23.19M
Research and development costs 20.02%607.16M28.61%174.69M6.52%162.37M31.63%133.1M17.61%137M43.23%505.87M36.02%135.83M60.87%152.43M35.04%101.12M39.19%116.49M
Depreciation amortization depletion 4.48%2.03M-14.89%503K-1.56%505K20.24%511K23.54%509K20.04%1.94M45.93%591K26.98%513K4.94%425K2.23%412K
-Depreciation and amortization 4.48%2.03M-14.89%503K-1.56%505K20.24%511K23.54%509K20.04%1.94M45.93%591K26.98%513K4.94%425K2.23%412K
Operating profit 116.36%98.35M127.19%44.11M6.01%-165.55M402.08%381.2M-18.21%-161.41M-193.21%-601.08M-49.73%-162.2M-71.51%-176.14M-362.00%-126.19M-224.07%-136.55M
Net non-operating interest income expense -440.61%-52.07M-69.07%-12.64M-1,051.78%-13.36M-1,109.66%-12.02M-447.52%-14.04M-218.20%-9.63M-442.99%-7.48M242.39%1.4M-100.00%-994K-1,435.93%-2.57M
Non-operating interest income 64.12%37.29M26.26%9.05M69.58%11.02M53.84%9.62M171.31%7.6M48.51%22.72M84.56%7.17M55.75%6.5M37.06%6.25M4.47%2.8M
Non-operating interest expense 176.21%89.36M48.11%21.69M378.64%24.38M198.72%21.64M303.32%21.65M76.54%32.35M178.35%14.65M-1.24%5.09M43.25%7.24M88.38%5.37M
Other net income (expense) 400.86%5.26M249.33%4.66M-123.16%-176K131.75%438K-19.00%341K-213.65%-1.75M-534.87%-3.12M148.37%760K2,262.50%189K-16.96%421K
Other non- operating income (expenses) 400.86%5.26M249.33%4.66M-123.16%-176K131.75%438K-19.00%341K-213.65%-1.75M-534.87%-3.12M148.37%760K2,262.50%189K-16.96%421K
Income before tax 108.41%51.53M120.90%36.12M-2.94%-179.09M391.05%369.62M-26.26%-175.12M-196.60%-612.46M-58.54%-172.8M-68.28%-173.98M-366.37%-127M-231.84%-138.69M
Income tax 874.09%21.42M3,563.00%20M-437K1.75M103.11%103K-199.39%-2.77M-73.04%546K00-19,588.24%-3.31M
Net income 104.94%30.11M109.30%16.12M-2.69%-178.65M389.67%367.86M-29.43%-175.22M-191.34%-609.69M-56.14%-173.34M-67.08%-173.98M-366.37%-127M-223.78%-135.38M
Net income continuous Operations 104.94%30.11M109.30%16.12M-2.69%-178.65M389.67%367.86M-29.43%-175.22M-191.34%-609.69M-56.14%-173.34M-67.08%-173.98M-366.37%-127M-223.78%-135.38M
Minority interest income 411.23%31.75M1,519.91%39.87M-7.13%-3.41M-52.24%-2.58M15.09%-2.13M-155.00%-10.2M-110.18%-2.81M-170.06%-3.18M-69.77%-1.7M-416.87%-2.51M
Net income attributable to the parent company 99.73%-1.63M86.07%-23.75M-2.60%-175.24M395.65%370.45M-30.27%-173.09M-192.04%-599.49M-55.49%-170.54M-65.91%-170.79M-357.42%-125.3M-221.51%-132.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 99.73%-1.63M86.07%-23.75M-2.60%-175.24M395.65%370.45M-30.27%-173.09M-192.04%-599.49M-55.49%-170.54M-65.91%-170.79M-357.42%-125.3M-221.51%-132.86M
Basic earnings per share 99.80%-0.0186.86%-0.188.70%-1.26372.55%2.78-12.10%-1.39-160.42%-5-34.31%-1.37-43.75%-1.38-321.74%-1.02-217.95%-1.24
Diluted earnings per share 99.80%-0.0186.86%-0.188.70%-1.26369.61%2.75-12.10%-1.39-160.42%-5-34.31%-1.37-43.75%-1.38-326.67%-1.02-217.95%-1.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.66%
Sample Name
Sample Code
 +3.47%
Sample Name
Sample Code
 +2.51%
4
Netflix
NFLX
+1.95%
5
NVIDIA
NVDA
+1.52%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.10%
Sample Name
Sample Code
 +8.77%
Sample Name
Sample Code
 +4.52%
4
H World Group
HTHT
+4.22%
5
KE Holdings
BEKE
+4.22%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -